Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.45 EUR | +1.82% | +1.13% | -36.80% |
Apr. 18 | Evotec, Variant Bio Team Up to Develop Treatment for Fibrosis | MT |
Apr. 18 | Evotec, Variant Bio Launch Partnership to Develop Treatments for Fibrosis | MT |
Sales 2023 * | 780M 830M | Sales 2024 * | 919M 978M | Capitalization | 2.38B 2.54B |
---|---|---|---|---|---|
Net income 2023 * | -54M -57.48M | Net income 2024 * | 31M 33M | EV / Sales 2023 * | 3 x |
Net cash position 2023 * | 46.3M 49.28M | Net cash position 2024 * | 37M 39.38M | EV / Sales 2024 * | 2.56 x |
P/E ratio 2023 * |
-43.4
x | P/E ratio 2024 * |
72.7
x | Employees | 5,086 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 90.64% |
Latest transcript on Evotec SE
1 day | +1.82% | ||
1 week | +0.67% | ||
Current month | -7.05% | ||
1 month | +6.58% | ||
3 months | -7.72% | ||
6 months | -22.16% | ||
Current year | -36.80% |
Managers | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Laetitia Rouxel
DFI | Director of Finance/CFO | 51 | 23-02-06 |
Craig Johnstone
COO | Chief Operating Officer | 54 | 12-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mario Polywka
CEO | Chief Executive Officer | 61 | 19-06-18 |
Roland Sackers
BRD | Director/Board Member | 56 | 19-06-18 |
Chairman | 63 | 14-06-16 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.68% | 17 M€ | -.--% | - | |
2.59% | 202 M€ | -.--% | ||
0.21% | 79 M€ | -.--% | ||
0.15% | 2 M€ | -.--% |
Date | Price | Change | Volume |
---|---|---|---|
24-04-18 | 13.45 | +1.82% | 694,213 |
24-04-17 | 13.21 | -0.15% | 617,970 |
24-04-16 | 13.23 | -3.99% | 570,194 |
24-04-15 | 13.78 | +0.07% | 337,584 |
24-04-12 | 13.77 | +3.53% | 1,078,369 |
Delayed Quote Xetra, April 18, 2024 at 11:40 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-36.80% | 2.49B | |
-1.82% | 41.36B | |
+44.25% | 41.3B | |
+2.56% | 39.61B | |
-12.11% | 25.62B | |
+3.09% | 24.09B | |
-24.16% | 18.38B | |
+22.12% | 11.85B | |
-3.74% | 11.82B | |
+7.75% | 11.07B |
- Stock Market
- Equities
- EVT Stock